Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Stephanie Sendek"'
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0123231 (2015)
Although Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized primarily by motor symptoms, PD patients, at all stages of the disease, can experience cognitive dysfunction. However, the relationships between cognitive and
Externí odkaz:
https://doaj.org/article/fb09418447eb45f7b0d5bf34754bac71
Autor:
Jay S. Schneider, Stephanie Sendek, Dean F. Wong, Stephen Gollomp, Benjamin E. Leiby, Hiroto Kuwabara, James Robert Brašić, Franca Cambi
Publikováno v:
Journal of the Neurological Sciences. 356:118-123
Objective GM1 ganglioside has been suggested as a treatment for Parkinson's disease (PD), potentially having symptomatic and disease modifying effects. The current pilot imaging study was performed to examine effects of GM1 on dopamine transporter bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::badbebc6e0f134f7f628908c51d8aa5e
https://doi.org/10.1016/j.jns.2015.06.028
https://doi.org/10.1016/j.jns.2015.06.028
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0123231 (2015)
PLoS ONE
PLoS ONE
Background Although Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized primarily by motor symptoms, PD patients, at all stages of the disease, can experience cognitive dysfunction. However, the relationships between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c4c527fa3ce9438399f4bd574961559
http://europepmc.org/articles/PMC4407885?pdf=render
http://europepmc.org/articles/PMC4407885?pdf=render
The present single center, double-blind, delayed start study was conducted to examine possible symptomatic and disease-modifying effects of GM1 ganglioside in Parkinson's disease (PD). Seventy-seven subjects with PD were randomly assigned to receive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::586652d2d5e79289ec6ca37987d6fb61
https://europepmc.org/articles/PMC3532888/
https://europepmc.org/articles/PMC3532888/
